Professor Rossant explains her research into embryonic stem cells and the potential of regenerative medicine.
Using mouse blastocysts as a model, Professor Rossant has spent her career focusing on embryonic development and tracing cell lineages, seeking to understand how and why cells differentiate in the embryo.
The field of stem cell research is now realising the potential of reprogrammed human stem cells for both regenerative medicine and personalised medical treatments. Professor Rossant explains her past work on treatments for cystic fibrosis, and also explores potential future uses of gene editing such as for Duchenne Muscular Dystrophy, using new methods to edit out harmful genes in ways that would have been impossible only a few years ago.
This talk explores both Professor Rossant’s own work, the medical ethics surrounding her field, and also some of the stories and people from along the way.
Professor Janet Rossant FRS is Senior Scientist for the Developmental and Stem Cell Biology Program at the Hospital for Sick Children (SickKids), Toronto, and a Professor in the Department of Molecular Genetics, and the Department of Obstetrics and Gynaecology. She is also President and Scientific Director of the Gairdner Foundation. Read more:
Professor Rossant gave this talk, ‘Stem cells and genome editing – from basic research to precision medicine’ as part of the Academy of Medical Sciences’ 2018 AGM and 20th anniversary celebrations.
We are the independent body in the UK representing the diversity of medical science. Our mission is to advance biomedical and health research and its translation into benefits for society.
Find the Academy of Medical Sciences online: